Jason O'Byrne - EVP & Chief Financial Officer at Vir Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Financial Officer
Issuer Symbol
VIR on Nasdaq
All Insider Reports
All Insider Reports

Jason O'Byrne - trading volume in the past year for Vir Biotechnology, Inc.

Holdings reported by Jason O'Byrne for Vir Biotechnology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 162,615 $1,550,143 $9.53 24 Feb 2026 Direct
Stock Option (Right to Buy) 110,000 $122,400 $1.53 22 Feb 2026 Direct Common Stock

Transactions reported by Jason O'Byrne for Vir Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.